The Spectrum of Endocrine Disorders in Patient Presented with Obstructive Sleep Apnea. A Cross-Sectional Study in Tertiary Care Hospital
DOI:
https://doi.org/10.70749/ijbr.v3i7.2222Keywords:
Obstructive sleep apnea, Endocrine disorders, Metabolic syndrome, Hypothyroidism, AcromegalyAbstract
Background: Obstructive sleep apnea has been increasingly acknowledged as a systemic illness with heterogeneous endocrine connections. The detection of concomitant endocrine diseases in patients with obstructive sleep apnea becomes crucial in the overall management and early treatment, particularly in risk groups. Objective: To determine the endocrine disorders in patients presented with obstructive sleep apnea. Study Design: Descriptive cross-sectional study. Duration and Place of Study: The study was conducted from February 2025 to May 2025 at the Department of Pulmonology, Ayub Teaching Hospital, Abbottabad. Methodology: A total of 77 patients aged 20–85 years with confirmed or suspected OSA were enrolled. Diagnosis was based on clinical sleepiness assessment and confirmatory sleep studies in selected cases. Patients underwent detailed history, clinical examination, and relevant investigations to screen for diabetes mellitus, hypothyroidism, acromegaly, metabolic syndrome, and polycystic ovary syndrome. Results: Metabolic syndrome was the most frequent condition, observed in 39 patients (50.6%), followed by hypothyroidism in 34 (44.2%), diabetes mellitus in 25 (32.5%), and acromegaly in 2 (2.6%). PCOS was detected in 2 out of 20 females (10%). Hypothyroidism was significantly more prevalent in urban patients (p=0.001). Conclusion: Endocrine disorders are prevalent among patients with obstructive sleep apnea, underscoring the need for routine endocrine screening to ensure timely diagnosis and holistic management.
Downloads
References
1. Platon AL, Stelea CG, Boișteanu O, Patrascanu E, Zetu IN, Roșu SN, et al. An update on obstructive sleep apnea syndrome-a literature review. Medicina (Kaunas). 2023;59(8):1459.
https://doi.org/10.3390/medicina59081459.
2. Lavalle S, Masiello E, Iannella G, Magliulo G, Pace A, Lechien JR, et al. Unraveling the complexities of oxidative stress and inflammation biomarkers in obstructive sleep apnea syndrome: a comprehensive review. Life (Basel). 2024;14(4):425.
https://doi.org/10.3390/life14040425.
3. Lal C, Weaver TE, Bae CJ, Strohl KP. Excessive daytime sleepiness in obstructive sleep apnea. Mechanisms and clinical management. Ann Am Thorac Soc. 2021;18(5):757-768.
https://doi.org/10.1513/AnnalsATS.202006-696FR.
4. Paschou SA, Bletsa E, Saltiki K, Kazakou P, Kantreva K, Katsaounou P, et al. Sleep apnea and cardiovascular risk in patients with prediabetes and type 2 diabetes. Nutrients. 2022;14(23):4989.
https://doi.org/10.3390/nu14234989.
5. McNicholas WT, Korkalainen H. Translation of obstructive sleep apnea pathophysiology and phenotypes to personalized treatment: a narrative review. Front Neurol. 2023;14:1239016.
https://doi.org/10.3389/fneur.2023.1239016.
6. Yu Z, Cheng JX, Zhang D, Yi F, Ji Q. Association between obstructive sleep apnea and type 2 diabetes mellitus: a dose-response meta-analysis. Evid Based Complement Alternat Med. 2021;2021:1337118.
https://doi.org/10.1155/2021/1337118.
7. Pancholi C, Chaudhary SC, Gupta KK, Sawlani KK, Verma SK, Singh A, et al. Obstructive sleep apnea in hypothyroidism. Ann Afr Med. 2022;21(4):403-409.
https://doi.org/10.4103/aam.aam_134_21.
8. Hashim Z, Gupta M, Nath A, Khan A, Neyaz Z, Tiwari S, et al. Prevalence of sleep apnea and lung function abnormalities in patients with acromegaly. Lung India. 2022;39(1):58-64.
https://doi.org/10.4103/lungindia.lungindia_182_21.
9. Sam S, Tasali E. Role of obstructive sleep apnea in metabolic risk in PCOS. Curr Opin Endocr Metab Res. 2021;17:46-51.
https://doi.org/10.1016/j.coemr.2021.01.002.
10. He J, Ruan X, Li J. Polycystic ovary syndrome in obstructive sleep apnea-hypopnea syndrome: an updated meta-analysis. Front Endocrinol (Lausanne). 2024;15:1418933.
https://doi.org/10.3389/fendo.2024.1418933.
11. Heffernan A, Duplancic D, Kumric M, Ticinovic Kurir T, Bozic J. Metabolic crossroads: unveiling the complex interactions between obstructive sleep apnoea and metabolic syndrome. Int J Mol Sci. 2024;25(6):3243.
https://doi.org/10.3390/ijms25063243.
12. Yang Z, Lv T, Jin L, Lv X, Zhu X, Wang X, et al. The relationship between obstructive sleep apnea and osteoarthritis: evidence from an observational and Mendelian randomization study. Front Neurol. 2024;15:1425327.
https://doi.org/10.3389/fneur.2024.1425327.
13. Gencer A, Atahan E, Kadioglu P, Mutlu B. Investigation of the frequency of obstructive sleep apnoea syndrome in patients with subclinical hypothyroidism. ERJ Open Res. 2022;8(4):110-114.
https://doi.org/10.1183/23120541.00186-2022
14. Polu SR, Reddy MR. Prevalence of hypothyroidism in obstructive sleep apnea. Int J Adv Med. 2016;3(1):15-19.
https://doi.org/10.18203/2349-3933.ijam20151383
15. Green ME, Bernet V, Cheung J. Thyroid dysfunction and sleep disorders. Front Endocrinol (Lausanne). 2021;12:725829.
https://doi.org/10.3389/fendo.2021.725829.
16. Wilding J, O'Reilly J. Sleep apnoea, obesity, diabetes and the metabolic syndrome. Eur Endocr Dis. 2007;72-75.
https://doi.org/10.17925/ee.2007.00.02.72
17. Pilarska M, Dżaman K, Szczepański D, Węgrzecki T. Craniofacial parameters and obstructive sleep apnea in newly diagnosed acromegaly. Front Endocrinol (Lausanne). 2025;16:1632944.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
